Junctophilin-4 (JPH4) is a member of the junctophilin family of proteins, which are known for their essential role in tethering the plasma membrane to the endoplasmic or sarcoplasmic reticulum in cells, forming closely apposed junctional membrane complexes. These complexes are vital for various cellular processes, including calcium signaling, which is pivotal for muscle contraction and neuronal activity. Junctophilins contain a conserved "MORN" (membrane occupation and recognition nexus) motif, which is believed to be involved in membrane binding. Junctophilin-4, specifically, is expressed in various tissues but is notably present in certain regions of the brain, suggesting a role in neuronal function and influencing calcium dynamics in neurons.
Inhibitors targeting Junctophilin-4 would be molecules designed to modulate the function, expression, or stability of the JPH4 protein. Given JPH4's role in forming junctional membrane complexes and its involvement in calcium signaling, inhibiting this protein could impact calcium homeostasis and the associated downstream cellular processes in the tissues where it is expressed. Inhibitors could comprise small molecules that bind directly to JPH4, preventing its interaction with the plasma membrane or the endoplasmic reticulum. By disrupting these interactions, the formation of the crucial junctional membrane complexes might be hindered. Another approach could involve molecules that influence post-translational modifications of JPH4, affecting its localization, stability, or interactions with other cellular components. Molecular strategies, such as RNA interference or antisense oligonucleotides, could also be harnessed to modulate JPH4 expression at the genetic level. Delving into the effects of JPH4 inhibition can provide valuable insights into its specific roles in cellular calcium dynamics and membrane junction formation. Such studies would contribute to a deeper understanding of cellular architecture and the intricate balance of ion homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the ER calcium ATPase, altering calcium homeostasis, which might indirectly affect JPH4 expression or function. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation in the ER, potentially affecting ER function and indirectly JPH4. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A disrupts ER-to-Golgi transport, potentially affecting proteins associated with the ER, including JPH4. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
2-APB modulates IP3 receptors and affects calcium signaling, which could indirectly influence JPH4 expression or function. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $219.00 $765.00 | 19 | |
Ryanodine modulates ryanodine receptors, affecting calcium release from the ER/SR, potentially impacting JPH4. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene inhibits ryanodine receptors, affecting calcium signaling, which might indirectly affect JPH4. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $94.00 $259.00 | 2 | |
Ionomycin is a calcium ionophore, increasing intracellular calcium levels, which might indirectly modulate JPH4 expression or function. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $173.00 $612.00 | 3 | |
An inhibitor of the sarcoplasmic reticulum Ca2+ ATPase, affecting calcium homeostasis and potentially JPH4. | ||||||
Xestospongin C | 88903-69-9 | sc-201505 | 50 µg | $500.00 | 14 | |
Xestospongin C is an IP3 receptor antagonist, potentially impacting calcium signaling and indirectly JPH4. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $101.00 $155.00 $389.00 $643.00 | 2 | |
SKF-96365 inhibits receptor-operated calcium channels, potentially affecting calcium signaling and JPH4. | ||||||